Freestone Grove Partners’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
VCM
VPM
Freestone Grove Partners's XYL Position: Q1 2026 in Review
Freestone Grove Partners reduced its Xylem (XYL) stake by 92% in Q1 2026, selling an estimated $20.1M and leaving 14,136 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #395.
Freestone Grove Partners first reported a position in XYL in Q1 2025 and has held it in 5 quarters since. The position peaked at $27.7M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- Freestone Grove Partners held 14,136 shares of Xylem worth $1.69M as of Q1 2026.
- Freestone Grove Partners sold 153,219 Xylem shares in Q1 2026, an estimated $20.1M.
- Xylem made up 0.01% of Freestone Grove Partners's portfolio in Q1 2026, its #395 holding.
- Freestone Grove Partners first reported a position in Xylem in Q1 2025 and has held it in 5 quarters since.
- Freestone Grove Partners's Xylem position peaked at $27.7M in Q3 2025.
- 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.